Skip to content

Clinical trials of cochlear implantation in patients with severe and profound neurosensory deafness assisted by the cochlear implantation surgical navigation system.

Clinical trials of cochlear implantation in patients with severe and profound neurosensory deafness assisted by the cochlear implantation surgical navigation system.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097920
Enrollment
Unknown
Registered
2025-02-27
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with severe or profound sensorineural hearing loss in both ears

Interventions

Experimental group:Perform cochlear implantation surgery with the assistance of the cochlear implantation surgical navigation system (Model and Specification: SBT-CIR1).

Sponsors

Shandong Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The age ranges from 7 to 60 years old. 2. Severe or profound sensorineural hearing loss in both ears. 3. Hearing aids are ineffective or have very poor effects, and the recognition rate of open short sentences under the condition of binaural hearing aid listening (70dBSPL) is <= 50%. 4. Auditory speech is the main way of daily communication. 5. There are no surgical contraindications and no other serious congenital malformations/complications. 6. The subjects have provided the signed informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Allergic to the materials of the implant. 2. Severe inner ear malformations (except congenital cochlear malformations (Mondini) and large vestibular aqueduct syndrome (LVAS)). 3. Deafness is caused by non-cochlear lesions. 4. There is an infection in the middle ear or the tympanic membrane perforation has not healed. 5. Patients with other serious diseases, such as diabetes, heart disease, etc. 6. Those with abnormal brain structures, such as abnormal white matter development, demyelinating diseases, etc. 7. Patients with epilepsy, intellectual disabilities, mental illnesses, scars, and hypersensitive constitutions. 8. Unable to cooperate with audiological evaluations and language training. 9. In poor general physical condition and unable to undergo surgery. 10. Those deemed inappropriate for enrollment by the researchers.

Design outcomes

Primary

MeasureTime frame
The treatment success rate;

Secondary

MeasureTime frame
Electrode implantation depth;The number of correctly inserted electrode contacts.;The success rate and insertion time of cochlear electrode arrays implanted through the drilled direct cochlear access.;The absolute angular accuracy of the drilled tunnel passage;

Countries

China

Contacts

Public ContactXu Lei

Shandong Second People's Hospital

lvmt801@163.com+86 135 5256 4506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026